dr. fukuoka on dosage for regorafenib/nivolumab combo in gastric cancer and crc
Published 5 years ago • 315 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:04
exploring regorafenib and nivolumab as treatment for colorectal cancer
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
1:46
dr. cusnir on the utility of regorafenib in gastric cancer
-
4:47
regorafenib nivolumab in mmr proficient advanced crc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
4:14
the use of regorafenib in clinical practice
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
2:10
regina: regorafenib, nivolumab, and scrt in rectal adenocarcinoma
-
2:08
dr. becerra discusses regorafenib dosing in metastatic crc
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
2:53
renobate: investigating regorafenib plus nivolumab as 1st-line therapy for unresectable hcc
-
1:25
dr. chau on nivolumab in asian versus western patients with gastric/gej cancer
-
9:34
regorafenib in colorectal cancer
-
1:05
dr. corcoran on the utility of regorafenib in crc
-
58:58
gi asco 2020 recap webinar
-
5:32
colorectal cancer: regorafenib patient selection and dosing